Table 3:
RGS10-associated loss of function phenotypes and disease links
| Phenotype(s) | Proposed disease links | Year | Reference(s) | 
|---|---|---|---|
| Impaired osteoclasts differentiation | Osteopetrosis | 2007 | [47, 111] | 
| Neuroinflammation and neurodegeneration | Parkinson’s disease and a possible link to schizophrenia | 2008 | [48, 94, 96] | 
| Reduced chemotherapy-induced cell death | Ovarian cancer chemoresistance | 2010 | [124, 125] | 
| Hypertrophy following pressure overload | Heart failure | 2015 | [108] | 
| Platelets aggregation and thrombogenesis | Aspirin resistance | 2016 | [119, 121] | 
| Increased body weight with insulin resistance and glucose intolerance | Obesity and related metabolic syndromes | 2019 | [131] |